Literature DB >> 517778

Propranolol binding in plasma during cardiopulmonary bypass.

M Wood, D G Shand, A J Wood.   

Abstract

The effect of cardiopulmonary bypass on the plasma binding of propranolol was examined in seven patients. The fraction of propranolol free in plasma doubled, increasing from 6.6 to 13.5 per cent (P less than 0.001) following the administration of heparin, 400 IU/kg. Once cardiopulmonary bypass was concluded and protamine, 8 mg/kg, given, the free fraction decreased from 13.4 to 8.7 per cent (P less than 0.005). There was a further significant decrease to 6.5 per cent over the next 3.1 hours (SE +/- 0.3). Those alterations in the free fraction, which would result in more drug being available for binding to receptor sites and for exerting its pharmacologic effect, were due principally to the changes in free fatty acid levels produced by heparin and protamine, but also to the hemodilution produced by the pump prime.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 517778     DOI: 10.1097/00000542-197912000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  Effect of heparin administration on plasma binding of benzodiazepines.

Authors:  P V Desmond; R K Roberts; A J Wood; G D Dunn; G R Wilkinson; S Schenker
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

Review 2.  Protein binding displacement interactions and their clinical importance.

Authors:  J C McElnay; P F D'Arcy
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

Review 3.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

4.  Propranolol disposition in renal failure.

Authors:  A J Wood; R E Vestal; C L Spannuth; W J Stone; G R Wilkinson; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

5.  Alcuronium kinetics in patients undergoing cardiopulmonary bypass surgery.

Authors:  J S Walker; K F Brown; C A Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

6.  Ceftriaxone disposition in open-heart surgery patients.

Authors:  G L Jungbluth; M T Pasko; T R Beam; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 7.  Pharmacokinetic drug interactions with propranolol.

Authors:  A J Wood; J Feely
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

Review 8.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

Review 9.  Cardiopulmonary bypass and the pharmacokinetics of drugs. An update.

Authors:  W A Buylaert; L L Herregods; E P Mortier; M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

10.  Population Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone in Neonates Undergoing Cardiopulmonary Bypass.

Authors:  Christoph P Hornik; Daniel Gonzalez; Julie Dumond; Huali Wu; Eric M Graham; Kevin D Hill; Michael Cohen-Wolkowiez
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.